Abstract
The aim of this chapter is to provide a comprehensive introduction to the new possibilities that Magnetic Resonance Spectroscopy (MRS) offers in clinical neurosciences. Focus will be on what MRS can do rather than what MRS is. For simplicity, basic physical and chemical principles will not be much explored and are referred to elsewhere.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References and suggestions for further reading
General reviews
Novotny E, Ashwal S, Shevell M (1998) Proton magnetic resonance spectroscopy: an emerging technology in pediatric neurology research. Pediatr Res 44 (1): 1–10
Rudkin TM, Arnold DL (1999) Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders. Arch Neurol 56 (8): 919–926
Vion-Dury J, Meyerhoff DJ, Cozzone PJ, Weiner MW (1994) What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy ? [ed] J Neurol 241 (6): 354–371
Iles RA, Burns SP (1995) In vitro NMR spectroscopy in the diagnosis and investigation of metabolic disorders. Quart. Magn Res Biol Med 2 (1): 35–42
Radda GK (1986) The use of NMR spectroscopy for the understanding of disease. Science 233 (4764): 640–645
Gruetter R, Weisdorf SA, Rajanayagan V, Terpstra M, Merkle H, Truwit CL, Garwood M, Nyberg SL, Ugurbil K (1998) Resolution improvements in in vivo 1H NMR spectra with increased magnetic field strength. J Magn Reson 135 (1): 260–264
MR principle
Andrew ER (1990) An introduction to nuclear magnetic resonance in biomedicine. Can Assoc Radiol J 41 (1): 2–7
Hoffenberg EF, Kozlowski P, Salerno TA, Deslauriers R (1996) Evaluation of cardiac 31P magnetic resonance spectroscopy: reviewing NMR principles. J Surg Res 62 (1): 135–143
Woodward P (2000) MRI for technologists. McGraw-Hill, p 432
Mitchell DG (1998) MRI Principles. Saunders, p 288
Longmore DB (1989) The principles of magnetic resonance. Br Med Bull 45 (4): 848–880
Wehrli WF, Shaw D, Kneeland JB (1988) Biomedical magnetic resonance imaging. VCH Publisher, New York, p 601
Gadian DG (1982) Nuclear Magnetic Resonance and its application to living systems. Clarendon, Press Oxford
Slichter CP (1978) Principles of Magnetic Resonance Spectroscopy. Second ed, Springer-Verlag, Berlin
Farrar TC, Becker ED (1971) Pulse and Fourier Transform NMR. Academic Press, New York
Experimental applications
Bollano E, Omerovic E, Bohlooly y M, Kujacic V, Madhu B, Tornell J, Isaksson O, Soussi B, Schulze W, Fu ML, Matejka G, Waagstein F, Isgaard J (2000) Impairment of cardiac function and bioenergetics in adult transgenic mice overexpressing the bovine growth hormone gene. Endocrinology 141 (6): 2229–2235
Lagerwall K, Daneryd P, Schersten T, Soussi B (1995) In vivo 31P nuclear magnetic resonance evidence of the salvage effect of ascorbate on the postischemic reperfused rat skeletal muscle. Life Sci 56 (6): 389–397
Lagerwall K, Madhu B, Daneryd P, Schersten T, Soussi B (1997) Purine nucleotides and phospholipids in ischemic and reperfused rat skeletal muscle: effect of ascorbate. Am J Physiol 272 (1 Pt 2): H83–90
Lukes D, Madhou B, Arvidsson N, Gustaysson M, Mjornstedt L, Soussi B, Olausson M (1997) In vivo 31P MRS evaluation of the rejection process and differences in anesthetic procedures in a concordant xenotransplantation: mouse heart to rat model. Transplant Proc 29 (7): 3159–3160
Madhu B, Lagerwall K, Soussi B (1996) Phosphorus metabolites in different muscles of the rat leg by 31P image–selected in vivo spectroscopy [published erratum appears in NMR Biomed (1997) 10(6): 302]. NMR Biomed 9 (8): 327–332
Omerovic E, Basetti M, Bollano E, Bohlooly M, Tornell J, Isgaard J, Hjalmarson A, Soussi B, Waagstein F (2000) In vivo metabolic imaging of cardiac bioenergetics in trans-genic mice. Biochem Biophys Res Commun 271 (1): 222–228
Omerovic E, Bollano E, Basetti M, Kujacic V, Waagstein L, Hjalmarson A, Waagstein F, Soussi B (1999) Bioenergetic, functional and morphological consequences of postinfarct cardiac remodeling in the rat. J Mol Cell Cardiol 31 (9): 1685–1695
Sorensen V, Jonsson O, Pettersson S, Schersten T, Soussi B (1998) In vivo 31P NMR OSIRIS of bioenergetic changes in rabbit kidneys during and after ischaemia: effect of pretreatment with an indeno-indole compound. Acta Physiol Scand 162 (4): 495–500
Soussi B, Idstrom JP, Bylund-Fellenius AC, Schersten T (1990) Dynamics of skeletal muscle energetics during ischemia and reperfusion assessed by in vivo 31P NMR. NMR Biomed 3 (2): 71–77
Soussi B, Lagerwall K, Idstrom JP, Schersten T (1993) Purine metabolic pathways in rat hindlimb perfusion model during ischemia and reperfusion. Am J Physiol 265 (4 Pt 2): H1074–1081
Hajek M, Burian M, Dezortova M (2000) Application of LCModel for quality control and quantitative in vivo 1H MR spectroscopy by short echo time STEAM sequence. Magma 10 (1): 6–17
Podo F, Henriksen O, Boyce WM, Leach MO, Leibfritz D, de Certaines JD (1998) Absolute metabolite quantification by in vivo NMR spectroscopy: I. Introduction, objectives and activities of a concerted action in biomedical research. Magn Reson Imaging 16 (9): 1085–1092
Chen W, Adriany G, Zhu XH, Gruetter R, Ugurbil K (1998) Detecting natural abundance carbon signal of NAA metabolite within 12-cm3 localized volume of human brain using 1H-[13C] NMR spectroscopy. Magn Reson Med 40 (2): 180–184
Epilepsy
Duc CO, Trabesinger AH, Weber OM, Meier D, Walder M, Wieser HG, Boesiger P (1998) Quantitative 1H MRS in the evaluation of mesial temporal lobe epilepsy in vivo. Magn Reson Imaging 16 (8): 969–979
Hajek M, Dezortova M, Komarek V (1998) 1H MR spectroscopy in patients with mesial temporal epilepsy. Magma 7(2): 95–114
Rothman DL, Behar KL, Prichard J1/V, Petroff OA (1997) Homocarnosine and the measurement of neuronal pH in patients with epilepsy. Magn Reson Med 38 (6): 924–929
van der Grond J, Gerson JR, Laxer KD, Hugg JW, Matson GB, Weiner MW (1998) Regional distribution of interictal 31P metabolic changes in patients with temporal lobe epilepsy. Epilepsia 39 (5): 527–536
Vainio P, Usenius JP, Vapalahti M, Partanen K, Kalviainen R, Rinne J, Kauppinen RA (1994) Reduced N-acetylaspartate concentration in temporal lobe epilepsy by quantitative 1H MRS in vivo. Neuroreport 5 (14): 1733–1736
Stroke and acute brain injuries
Blamire AM, Graham GD, Rothman DL, Prichard JW (1994) Proton spectroscopy of human stroke: assessment of transverse relaxation times and partial volume effects in single volume steam MRS. Magn Reson Imaging 12 (8): 1227–1235
Ford CC, Griffey RH, Matwiyoff NA, Rosenberg GA (1992) Multivoxel 1H-MRS of stroke. Neurology 42 (7): 1408–1412
Friedman SD, Brooks WM, Jung RE, Chiulli SJ, Sloan JH, Montoya BT, Hart BL, Yeo RA (1999) Quantitative proton MRS predicts outcome after traumatic brain injury. Neurology 52 (7): 1384–1391
Gideon P, Rosenbaum S, Sperling B, Petersen P (1999) MR-visible brain water content in human acute stroke. Magn Reson Imaging 17 (2): 301–304
Holshouser BA, Ashwal S, Shu S, Hinshaw DB Jr (2000) Proton MR spectroscopy in children with acute brain injury: comparison of short and long echo time acquisitions. J Magn Reson Imaging 11 (1): 9–19
Ross BD, Ernst T, Kreis R, Haseler LJ, Bayer S, Danielsen E, Bluml S, Shook T, Mandigo JC, Caton W, Clark C, Jensen SW, Lehman NL, Arcinue E, Pudenz R, Shelden CH (1998) H MRS in acute traumatic brain injury. J Magn Reson Imaging 8(4): 829–840
Wardlaw JM, Marshall I, Wild J, Dennis MS, Cannon J, Lewis SC (1998) Studies of acute ischemic stroke with proton magnetic resonance spectroscopy: relation between time from onset, neurological deficit, metabolite abnormalities in the infarct, blood flow, and clinical outcome. Stroke 29 (8): 1618–1624
Schizophrenia
Keshavan MS, Sanders RD, Pettegrew JW, Dombrowsky SM, Panchalingam KS (1993) Frontal lobe metabolism and cerebral morphology in schizophrenia: 31P MRS and MRI studies. Schizophr Res 10 (3): 241–246
Nasrallah HA, Skinner TE, Schmalbrock P, Robitaille PM (1994) Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study. Br J Psychiatry 165 (4): 481–485
Riehemann S, Volz HP, Smesny S, Hubner G, Wenda B, Rossger G, Sauer H (2000) Phosphorus 31 magnetic resonance spectroscopy in schizophrenia research. Pathophysiology of cerebral metabolism of high-energy phosphate and membrane phospholipids. Nervenarzt 71 (5): 354–363
Sigmundsson T, Maier M, Williams SCR, Simmons A, Greenwood K, Ron MA (1997) Frontal lobe in vivo proton magnetic resonance spectroscopy in schizophrenic patients with negative symptoms. Schizophrenia Research 24 (1–2): 182
Cancer
Castillo M, Kwock L (1999) Clinical applications of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumors. Top Magn Reson Imaging 10 (2): 104–113
Kim SH, Chang KH, Song IC, Han MH, Kim HC, Kang HS, Han MC (1997) Brain abscess and brain tumor: discrimination with in vivo H-1 MR spectroscopy [see comments]. Radiology 204 (1): 239–245
Leach MO (1996) Introduction to in vivo MRS of cancer: new perspectives and open problems. Anticancer Res 16 (3B): 1503–1514
Negendank W, Li CW, Padavic-Shaller K, Murphy-Boesch J, Brown TR (1996) Phospholipid metabolites in 1Hdecoupled 31P MRS in vivo in human cancer: implications for experimental models and clinical studies. Anticancer Res 16 (3B): 1539–1544
Sijens PE, Levendag PC, Vecht CJ, van Dijk P, Oudkerk M (1996) IH MR spectroscopy detection of lipids and lactate in metastatic brain tumors. NMR Biomed 9(2): 65–71
Multiple sclerosis and ALS
Arnold DL, Matthews PM, Francis G, Antel J (1990) Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn Reson Med 14 (1): 154–159
Block W, Karitzky J, Traber F, Pohl C, Keller E, Mundegar RR, Lamerichs R, Rink H, Ries F, Schild HH, Jerusalem F (1998) Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch Neurol 55 (7): 931–936
Leary SM, Brex PA, MacManus DG, Parker GJ, Barker GJ, Miller DH, Thompson AJ (2000) A (1)H magnetic resonance spectroscopy study of aging in parietal white matter: implications for trials in multiple sclerosis. Magn Reson Imaging 18 (4): 455–459
Rooney WD, Miller RG, Gelinas D, Schuff N, Maudsley AA, Weiner MW (1998) Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology 50 (6): 1800–1805
Sarchielli P, Presciutti O, Tarducci R, Gobbi G, Alberti A, Pelliccioli GP, Orlacchio A, Gallai V (1998) IH-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-la: results of a preliminary study. J Neurol Neurosurg Psychiatry 64(2): 204–212
Encephalommyopathy and metabolic diseases
Soussi B, Schersten T, Waldenstrom A, Ronquist G (1993) Phosphocreatine turnover and pH balance in forearm muscle of patients with syndrome X [letter]. Lancet 341 (8848): 829–830
Ronquist G, Soussi B, Frithz G, Schersten T, Waldenstrom A (1995) Disturbed energy balance in skeletal muscle of patients with untreated primary hypertension. J Intern Med 238 (2): 167–174
Kuhl CK, Layer G, Traber F, Zierz S, Block W, Reiser M (1994) Mitochondrial encephalomyopathy: correlation of P-31 exercise MR spectroscopy with clinical findings. Radiology 192 (1): 223–230
Mathews PM, Andermann F, Silver K, Karpati G, Arnold DL (1993) Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 43 (12): 2484–2490
Alzheimer’s disease and dementia
Cuenod CA, Kaplan DB, Michot JL, Jehenson P, Leroy-Willig A, Forette F, Syrota A, Boller F (1995) Phospholipid abnormalities in early Alzheimer’s disease. In vivo phosphorus 31 magnetic resonance spectroscopy. Arch Neurol 52 (1): 89–94
Moats RA, Ernst T, Shonk TK, Ross BD (1994) Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 32 (1): 110–115
Ross BD, Bluml S, Cowan R, Danielsen E, Farrow N, Gruetter R (1997) In vivo magnetic resonance spectroscopy of human brain: the biophysical basis of dementia. Biophys Chem 68 (1–3): 161–172
Schofield PW, Mosesson RE, Stern Y, Mayeux R (1995) The age at onset of Alzheimer’s disease and an intracranial area measurement. A relationship. Arch Neurol 52 (1): 95–98
Schuff N, Amend D, Ezekiel F, Steinman SK, Tanabe J, Norman D, Jagust W, Kramer JH, Mastrianni JA, Fein G, Weiner MW (1997) Changes of hippocampal N-acetyl aspartate and volume in Alzheimer’s disease. A proton MR spectroscopic imaging and MRI study. Neurology 49 (6): 1513–1521
Rights and permissions
Copyright information
© 2003 Springer-Verlag France
About this chapter
Cite this chapter
Soussi, B. (2003). In vivo Magnetic Resonance Spectroscopy in neurosciences. In: MRI Principles of the Head, Skull Base and Spine. Springer, Paris. https://doi.org/10.1007/978-2-8178-0754-6_2
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0754-6_2
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0756-0
Online ISBN: 978-2-8178-0754-6
eBook Packages: Springer Book Archive